International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2020 - Volume 24, Number 4
View All Articles in Issue

Page(s): 316

Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, hydroxychloroquine sulfate, antimalarial agent, malaria, lupus erythematosus, antirheumatic agent, rheumatic diseases, rheumatoid arthritis, COVID-19 pandemic, coronavirus, SARS-CoV-2

Related Categories: FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, INFECTIOUS DISEASE, MUSCULOSKELETAL DISORDERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Allen Loyd V Jr	Jul/Aug 2020 Pg. 316
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Allen Loyd V Jr	Nov/Dec 2017 Pg. 494
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Hydroxychloroquine Sulfate 200-mg Capsules Allen Loyd V Jr	Jan/Feb 2015 Pg. 66
Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes McHenry Adam R, Wempe Michael F, Rice Peter J	May/Jun 2017 Pg. 251-254
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 144
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic McElhiney Linda F	Jul/Aug 2020 Pg. 287-295
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Allen Loyd V Jr	Nov/Dec 2018 Pg. 496
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Allen Loyd V Jr	Sep/Oct 2019 Pg. 413
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 57
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 51
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 58
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 52
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants Riepl Mike	Jan/Feb 2023 Pg. 12-21
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 51
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Nov/Dec 2022 Pg. 513
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	May/Jun 2022 Pg. 241
Return to Top